Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Dorzolamide hydrochloride 22.26 mg/mL equivalent to 20 mg/mL dorzolamide, timolol maleate 6.83 mg/mL equivalent to 5 mg/mL timolol Drops, eye, solution Laboratoires Merck Sharp & Dohme - Chibret, Clermont-Ferrand, France; and Merck Sharp & Dohme BV/MMD Holland, Haarlem, The Netherlands Cosopt Varicella vaccine 1 350PFU in 0.5 mL; and water for injection 0.7 mL (as diluent) Injection, suspension, with diluent Merck & Co Inc., West Point, Pennsylvania, United States of America Varivax Dated this 28th day of May 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.